Series A funding round for Rubedo Life Sciences raising $40M in April 2024
Series A funding round for Rubedo Life Sciences raising $40M in April 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Varsha Rao |
| Angel | Justin Mateen |
| Angel | Balaji Srinivasan |
| Angel | Fidji Simo |
| Angel | Dan Ciporin |
| Angel | Anne Wojcicki |
| Angel | Amjad Masad |
| Angel | Andy Coravos |
| Angel | Rich Miner |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$52M
Top Valuation
-
Rubedo Life Sciences raised $40M in a Series A round.
The round was announced on 04/01/24.